Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells

Blood

Volumn 95, Issue 2, 2000, Pages 437-444

  Davis, Brian R ^a   Yannariello Brown, Judith ^b   Prokopishyn, Nicole L ^c   Luo, Zhongjun ^d   Smith, Mark R ^a   Wang, Jue ^a   Victor Carsrud, N D ^b   Brown, David B ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Gene Cell Inc   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MICROINJECTION; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0034651038     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.437     Document Type: Article

References (36)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993:81:28442853.
2. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996:2:1329-1337.
3. Uchida N, Sutton RE, Priera AM, et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated Go/G, human hematopoietic stem cells. Proc Natl Acad Sei USA. 1998:95:11,939-11,944.
4. Haibert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Viral. 1995:69:1473-1479.
5. Harrison GS, Wang Y, Tomczak J, et al. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4 and CD34+ hematopoietic cells. Biotechniques. 1995:19:816823.
6. Diacumakos EG, Holland S, Pecora P. A microsurgical methodology for human cells in vitro: evolution and applications. Proc Natl Acad Sei USA. 1970;65:911-918.
7. Grassmann A. Microsurgical cell nucleus transplantation in mammalian cells. Exp Cell Res. 1970:60:373-382.
8. Huberman M, Berg PE, Curcio MJ. DiPietra J, Henderson AS, Anderson WF. Fate and structure of DNA microinjected into mouse TK-L cells. Exp Cell Res. 1984:153:347-362.
9. Capecchi MR. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell. 1980:22:479-488.
10. Klein C, Raab-Traub N. Human neonatal lymphocytes immortalized after microinjection of Epstein-Barr virus DNA. J Virol. 1987;61:1552-1558.
11. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science. 1995:267:104-108.
12. Hemler ME, Sanchez-Madrid F, Flotte TJ, et al. Glycoproteins of 210,000 and 130,000 M.W. on activated T-cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1994;132:3011-3018.
13. Son'ano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 1991 ;64:693-702.
14. Shultz LD, Schweitzer PA, Christianson SW, et at. Multiple defects in Innate and adaptive immunologie function in NOD/LtSz-scid mice. J Immunol. 1995:154:180-191.
15. +-enriched cells from umbilical cord blood in NOD/ LtSz-sc/d/sc/dmice. Blood. 1997:90:85-96.
16. Levesque JP, Leavesley Dl, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med. 1995:181:1805-1815.
17. Kimizuka F, Taguchi Y, Ohdate Y, et al. Production and characterization of functional domains of human libronectin expressed in Escherichia coll. J Biochem. 1991 ;110:284-291.
18. Civin CI. Human monomyeloid cell membrane antigens. Exp Hematol. 1990:18:461-467.
19. Larochelle A, Vormoor J, Lapidot T, et al. Engraltment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet. 1995:4:163-172.
20. Pepperkok R, Schneider C, Philipson L, Ansorge W. Single cell assay with an automated capillary microinjection system. Exp Cell Res. 1988:178:369-376.
21. Conneally E, Cashman J, Petzer AL, Eaves AC. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-sc/cfsc/dmice. Proc Natl Acad Sei USA. 1997:94:9836-9847.
22. Goodell MA, Rosenweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997; 3:1337-1345.
23. Bhatia M, Bonnet D, Murdoch B, Gan O, Dick JE. A newly discovered class of human hematopoi-etic cells with scid-repopulating activity. Nat Med. 1998:4:1038-1045.
24. - cells in cord blood and bone marrow. Blood. 1995:86:3745-3753.
25. Bhatia M, Wang JCY. Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sei USA. 1997:94:5320-5325.
26. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc.Natl.Acad. Sci.USA. 1992:89:2804-2808.
27. Mayani H, Lansdorp PM. THY-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human unbilical cord blood. Blood. 1994:83:2410-2417.
28. Diacumakos EG, Killos L, Lee L, Anderson WF. Induction of mouse erythroleukemia cells by microinjection of inducing compound. Exp.Cell Res. 1981:131:73-77.
29. Graessmann M, Graessmann A. Microinjection of tissue culture cells. Methods Enzymol. 1983:101: 482-492.
30. Graessmann A, Wolf H, Bomkamm GW. Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc.NatI.Acad.Sci.USA. 1980;77:433-436.
31. Arroyo AG, Sanchez-Mateos P, Campanero MR, Martin-Padura I, Dejana E, Sanchez-Madrid F. Regulation of the VLA integrin-ligand interactions through the B1 subunit. J Cell Biol. 1992:117:659670.
32. Kurteberg J, Laughlin M, Graham ML, et al. Piacental blood as a source of hematopoietic stem cells for transplantation Into unrelated recipients. N Engl.J.Med. 1996:335:157-166.
33. Jones RJ, Collector Ml, Barber JP, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 1996:88:487-491.
34. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34- low/negative hematopoietic stem cell. Science. 1996;273:242-245.
35. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood. 1996; 87:3082-3088.
36. Cardoso AA, Li ML, Batard P, et al. Release from quiescence of CD34 CD38 human umbilical cord blood cells reveals their potentiality to engraft adults. Proc.Natl.Acad.Sci.USA. 1993;90: 8707-8711.